Company news
Lupin Limited (NSE:LUPIN) news
Lupin Limited news releases on 6ix. Latest, Oct 6, 2026: Lupin Limited has informed the Exchange regarding a press release dated October 06, 2026, titled…
Press releases & updates
Lupin Limited has informed the Exchange regarding a press release dated October 06, 2026, titled "Lupin Launches Formoflo-G® MDI, World s First Fixed-dose Triple Combination Drug for COPD Management".
October 6, 2026
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
September 28, 2026
Lupin Limited Press Release Sep 28 2026
September 27, 2026
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
September 4, 2026
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
August 20, 2026
Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
August 17, 2026
Lupin Limited Press Release Aug 17 2026
August 17, 2026
Lupin Limited Press Release Aug 10 2026
August 10, 2026
Lupin Limited Press Release Aug 06 2026
August 6, 2026
Lupin Limited Press Release Jul 31 2026
July 31, 2026
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
July 30, 2026
Lupin Limited Press Release Jul 14 2026
July 13, 2026
Lupin Named Among World's Most Sustainable Companies by TIME and Statista
July 6, 2026
Lupin Limited Press Release Jul 06 2026
July 6, 2026
Lupin Limited Press Release Jul 01 2026
July 1, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Limited Press Release Jun 26 2026
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026
Press Release Jun 08 2026
June 8, 2026
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
June 4, 2026
Press Release Jun 04 2026
June 4, 2026
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
June 3, 2026
Press Release Jun 03 2026
June 3, 2026
Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets
May 29, 2026
Press Release May 29 2026
May 29, 2026
Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026
May 28, 2026
Press Release May 28 2026
May 28, 2026
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
May 22, 2026
Press Release May 22 2026
May 22, 2026
Press Release May 19 2026
May 19, 2026
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
May 18, 2026
Press Release May 18 2026
May 18, 2026
Press Release May 15 2026
May 15, 2026
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
May 13, 2026
Press Release May 13 2026
May 13, 2026
Press Release May 07 2026
May 7, 2026
Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid
May 5, 2026
Press Release May 05 2026
May 4, 2026
Press Release Apr 22 2026
April 22, 2026
Lupin Limited Press Release Apr 22 2026
April 21, 2026
Press Release Apr 10 2026
April 10, 2026
Press Release Apr 08 2026
April 8, 2026
Press Release Apr 07 2026
April 7, 2026
Press Release Apr 02 2026
April 2, 2026
Lupin Completes Acquisition of VISUfarma
April 2, 2026
Press Release Mar 31 2026
March 31, 2026
Lupin Limited Press Release Mar 31 2026
March 30, 2026
Press Release Mar 25 2026
March 25, 2026
Lupin Limited Press Release Mar 25 2026
March 24, 2026
Press Release Mar 19 2026
March 19, 2026